Phibro Animal Health To Go Ex-Dividend On September 4th, 2024 With 0.12 USD Dividend Per Share
Phibro Animal Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Phibro Animal Health Is Maintained at Underperform by B of A Securities
Phibro Animal Health Analyst Ratings
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $15
Barclays Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $13
Phibro Animal Health (PAHC) Receives a Sell From Barclays
Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript Summary
Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
Phibro Q4 Earnings and Revenues Beat, Operating Margin Down
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $13
Phibro Animal Health Sell Rating: Concerns Over Operating Leverage and Profitability Despite Revenue Growth
Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Veeva Systems (VEEV)
Phibro Animal Health (PAHC) Beats Q4 Earnings and Revenue Estimates
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q4 Revenue $273.2M, Vs. Street Est of $260.5M
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Reports Q4 EPS $0.41, Vs. Street Est of $0.33
Express News | Phibro Animal Health Corp: Sees Fiscal Year 2025 Net Sales of $1.040 Bln to $1.090 Bln
Express News | Phibro Animal Health Q4 Adjusted Net Income USD 16.7 Million
Express News | Phibro Animal Health Q4 Adjusted Ebitda USD 33.4 Million